Expert Opinion on Therapeutic Targets

The continuing complexities of high-density lipoprotein metabolism in drug discovery and development
pp. 1133-1136(4)
Author: Suckling, Keith

Trial design for cancer (cell)-specific anticancer therapies
pp. 1137-1141(5)
Authors: van Alphen, Robbert J; Verweij, J; Eskens, FALM

Endothelial function, arterial stiffness and lipid lowering drugs
pp. 1143-1160(18)
Authors: Tziomalos, Konstantinos; Athyros, Vasilios G; Karagiannis, Asterios; Mikhailidis, Dimitri P

Pharmacologic targets for atrial fibrillation
pp. 1161-1178(18)
Authors: Bhakta, Deepak; Miller, John M

Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists
pp. 1179-1188(10)
Author: Edvinsson, Lars

Schizophrenia endophenotypes as treatment targets
pp. 1189-1206(18)
Author: Thaker, Gunvant K

Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors
pp. 1207-1217(11)
Authors: Park, Serk In; Shah, Ami N; Zhang, Jing; Gallick, Gary E

Targeting tumour-associated macrophages
pp. 1219-1229(11)
Authors: Sica, Antonio; Rubino, Luca; Mancino, Alessandra; Larghi, Paola; Porta, Chiara; Rimoldi, Monica; Solinas, Graziella; Locati, Massimo; Allavena, Paola; Mantovani, Alberto

Present and future therapeutic strategies in non-alcoholic fatty liver disease
pp. 1231-1249(19)
Authors: Calamita, Giuseppe; Portincasa, Piero

British Pharmacology Society 2nd Focused Meeting on Cell Signalling: GPCRs have sunny days in springtime Leicester
pp. 1251-1253(3)
Author: Insel, Paul A